The other risk is that by the time it takes to get RC220 into the clinic, another drug has made it to market which makes Bisantrene redundant as CP... (FTO and AC still viable)
Google, "experimental cardio protection drugs for chemo" and thousands of articles/reports pop up.
eg - https://www.einsteinmed.edu/news/2281/experimental-drug-may-prevent-chemotherapy-drug-from-damaging-the-heart/
-
- There are more pages in this discussion • 169 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.14 |
Change
-0.015(1.30%) |
Mkt cap ! $197.1M | |||
| Open | High | Low | Value | Volume |
| $1.16 | $1.16 | $1.13 | $170.4K | 148.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5868 | $1.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.14 | 2062 | 1 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| RAC (ASX) Chart |